1-4 of 4
Sarath Kanekal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A159: Dianhydrogalactitol (VAL-083) enhances activity of platinum drugs in non-small cell lung cancer

Anne Steino, Jeffrey A. Bacha, Guanghan He, Sarath Kanekal, Nancy Dos Santos, Shun Lu, Dennis M. Brown, Zahid H. Siddik
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A159.
https://doi.org/10.1158/1535-7163.TARG-15-A159
Published: 01 December 2015
View article titled, Abstract A159: Dianhydrogalactitol (VAL-083) enhances activity of platinum drugs in non-small cell lung cancer
Journal Articles

Abstract B252: The unique mechanism of action of VAL-083 may provide a new treatment option for some chemo-resistant cancers.

Anne Steino, Jeffrey A. Bacha, William J. Garner, Sarath Kanekal, Zahid H. Siddik, Dennis M. Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B252.
https://doi.org/10.1158/1535-7163.TARG-13-B252
Published: 01 November 2013
View article titled, Abstract B252: The unique mechanism of action of VAL-083 may provide a new treatment option for some chemo-resistant cancers.
Journal Articles

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge, David Bearss, Gregory Berk, Sarath Kanekal, Sanjeev Redkar, Pietro Taverna, David B. Agus, Anjali Jain
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2882–2893.
https://doi.org/10.1158/1535-7163.MCT-09-0293
Published: 12 October 2009
View article titled, Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
Open the PDF for Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes in another window
Journal Articles

Circadian pharmacology of l-alanosine (SDX-102) in mice

Xiao-Mei Li, Sarath Kanekal, Delphine Crépin, Catherine Guettier, Jennifer Carrière, Gary Elliott, Francis Lévi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (2): 337–346.
https://doi.org/10.1158/1535-7163.MCT-05-0332
Published: 27 February 2006
View article titled, Circadian pharmacology of <sc>l</sc>-alanosine (SDX-102) in mice
Open the PDF for Circadian pharmacology of <sc>l</sc>-alanosine (SDX-102) in mice in another window